Kestra Private Wealth Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $556K | Sell |
33,164
-434
| -1% | -$7.27K | 0.01% | 981 |
|
|
2025
Q1 | $516K | Buy |
33,598
+2,072
| +7% | +$31.8K | 0.01% | 938 |
|
|
2024
Q4 | $695K | Buy |
31,526
+21,075
| +202% | +$464K | 0.01% | 784 |
|
|
2024
Q3 | $188K | Sell |
10,451
-21,918
| -68% | -$395K | ﹤0.01% | 1277 |
|
|
2024
Q2 | $526K | Buy |
32,369
+7,013
| +28% | +$114K | 0.01% | 807 |
|
|
2024
Q1 | $358K | Sell |
25,356
-2,681
| -10% | -$37.8K | 0.01% | 940 |
|
|
2023
Q4 | $293K | Buy |
28,037
+146
| +0.5% | +$1.52K | 0.01% | 958 |
|
|
2023
Q3 | $284K | Sell |
27,891
-1,009
| -3% | -$10.3K | 0.01% | 884 |
|
|
2023
Q2 | $218K | Buy |
28,900
+2,000
| +7% | +$15.1K | 0.01% | 938 |
|
|
2023
Q1 | $238K | Sell |
26,900
-685
| -2% | -$6.06K | 0.01% | 854 |
|
|
2022
Q4 | $252K | Buy |
27,585
+5,168
| +23% | +$47.1K | 0.01% | 720 |
|
|
2022
Q3 | $181K | Sell |
22,417
-3,495
| -13% | -$28.2K | 0.01% | 798 |
|
|
2022
Q2 | $195K | Sell |
25,912
-612
| -2% | -$4.61K | 0.01% | 809 |
|
|
2022
Q1 | $249K | Buy |
26,524
+1,100
| +4% | +$10.3K | 0.01% | 806 |
|
|
2021
Q4 | $204K | Sell |
25,424
-2,646
| -9% | -$21.2K | 0.01% | 902 |
|
|
2021
Q3 | $273K | Hold |
28,070
| – | – | 0.02% | 745 |
|
|
2021
Q2 | $278K | Buy |
28,070
+4,974
| +22% | +$49.3K | 0.02% | 704 |
|
|
2021
Q1 | $267K | Buy |
23,096
+857
| +4% | +$9.91K | 0.02% | 639 |
|
|
2020
Q4 | $213K | Buy |
22,239
+3,275
| +17% | +$31.4K | 0.02% | 654 |
|
|
2020
Q3 | $171K | Buy |
+18,964
| New | +$171K | 0.01% | 615 |
|